We are monitoring the impact of COVID-19 on APAC Molecular Cytogenetics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3095
Share on
Share on

Asia Pacific Molecular Cytogenetics Market Research Report - Segmented By Product, Technique, Application, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3095
Pages: 178

APAC Molecular Cytogenetics Market Size (2021 to 2026)

The Asia Pacific Molecular Cytogenetics Market size was worth USD 461.25 million in 2021. This figure is further estimated to develop at a CAGR of 12.5% and value USD 831.19 million by 2026.

Molecular cytogenetics is a branch of molecular biology and cytogenetics that examines the chromosomal structure to distinguish between healthy and cancerous cells in the Asia Pacific.

Higher usage of genetic information in illness prediction models directly impacts cytogenetic technologies, resulting in increased growth generation for the molecular cytogenetics market in the APAC region. One of the major factors promoting the market's growth is the increase in the incidence of cancer and. The growing number of new cancer cases has underlined the need for better products to acquire a complete genomic understanding of the disease. Furthermore, molecular cytogenetics in clinical and research laboratories requires a large financial investment. The tools necessary for cytogenetics research and treatment are expensive due to their numerous features and functions.

On the other hand, software and services are expected to become a major source of revenue during the forecast period as solutions and algorithms to manage and comprehend massive volumes of genetic data continue to improve. In addition, ongoing genomic research initiatives have produced a surplus of genomic findings. As a result, businesses are investing in developing robust software and algorithms to facilitate cytogenetic analysis. As numerous cytogenetic methods have been effectively used for pharmacogenomic biomarker investigations, growing activities in pharmacogenomics are expected to have a substantial impact on market growth during the forecast period.

However, the application of molecular cytogenetics in cancer and personalized care could be hampered by a lack of reliable coverage and reimbursement rules for emerging genomic techniques. Furthermore, the scarcity of experienced employees and the high cost of maintaining and handling modern procedures are projected to stymie the growth of the molecular cytogenetics market in the APAC region during the forecast period.

This research report on the Asia Pacific molecular cytogenetics market has been segmented and sub-segmented into the following categories:

By Product:

  • Kits & Reagents
    • Testing Kits
    • Probes
    • Fluorescent Affinity Reagents
    • Other Kits & Reagents
  • Instruments
  • Consumables
  • Software & Services

By Technique:

  • Comparative Genomic Hybridization
    • Array-Based Comparative Genomic Hybridization
    • Standard Comparative Genomic Hybridization
  • Fluorescence in Situ Hybridization
  • In Situ Hybridization
  • Others

By Application: 

  • Genetic Disorders
  • Cancer
  • Personalized Medicine
  • Other Applications

By End User:

  • Clinical & Research Laboratories
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia-Pacific region is expected to be one of the fastest-growing regions during the forecast period across the world. Establishing an effective regulatory framework for the regulation of genetic tests has greatly helped the regional sector. Furthermore, increased industrialization in several countries such as India, China, and India is expected to support market growth. Furthermore, in response to the increased demand for cytogenetic analysis among the general public, manufacturers are making significant investments to expand their product offerings.

Forming mutually beneficial ties with laboratories and research institutes on a regional level helps these firms produce more revenue. As a result, continuous GDP growth in countries like China and India is predicted to improve regional consumer purchasing power during the forecast period.

KEY MARKET PLAYERS:

Companies playing a notable role in the Asia Pacific Molecular Cytogenetics Market profiled in the report are Affymetrix, Inc, Agilent Technologies, Inc, Illumina, Inc, Abbott Laboratories, Bio-Rad Laboratories, Inc, Applied Spectral Imaging, Inc, Thermo Fisher Scientific (Life Technologies), Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Kits & Reagents     

                                                5.1.1.1 Testing Kits

                                                5.1.1.2 Probes

                                                5.1.1.3 Fluorescent Affinity Reagents

                                                5.1.1.4 Other Kits & Reagents

                                5.1.2 Instruments           

                                5.1.3 Consumables         

                                5.1.4 Software & Services            

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By Product              

                5.2 Technique                   

                                5.2.1 Comparative Genomic Hybridization           

                                                5.2.1.1 Array-Based Comparative Genomic Hybridization

                                                5.2.1.2 Standard Comparative Genomic Hybridization

                                5.2.2 Fluorescence in Situ Hybridization

                                5.2.3 In Situ Hybridization            

                                5.2.4 Other Techniques

                                5.2.5 Y-o-Y Growth Analysis, By Technique          

                                5.2.6 Market Attractiveness Analysis, By Technique        

                                5.2.7 Market Share Analysis, By Technique          

                5.3 Application                 

                                5.3.1 Genetic Disorders

                                5.3.2 Cancer      

                                5.3.3 Personalised Medicine      

                                5.3.4 Other Applications               

                                5.3.5 Y-o-Y Growth Analysis, By Application         

                                5.3.6  Market Attractiveness Analysis, By Application      

                                5.3.7  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Clinical & Research Laboratories    

                                5.4.2 Academic Research Institutes         

                                5.4.3 Pharmaceutical and Biotechnology Companies       

                                5.4.4 Other End Users   

                                5.4.5 Y-o-Y Growth Analysis, By End User             

                                5.4.6  Market Attractiveness Analysis, By End User          

                                5.4.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Technique

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Technique

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Technique

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 F. Hoffmann-La Roche Ltd. (Switzerland)                      

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation (U.S.)                 

                8.3 Thermo Fisher Scientific                        

                8.4 Inc. (U.S.)                    

                8.5 Abbott Laboratories (U.S.)                   

                8.6 Agilent Technologies (U.S.)                 

                8.7 PerkinElmer, Inc. (U.S.)                         

                8.8 Illumina, Inc. (U.S.)                  

                8.9 Bio-Rad Laboratories (U.S.)                 

                8.10 Oxford Gene Technology (U.K.)                      

                8.11 Applied Spectral Imaging (U.S.)                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Molecular Cytogenetics Market, By Product & Service, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Kits and Reagents Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Testing Kits Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Probes Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific Fluorescent Affinity Reagents Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific Instruments Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Consumables Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Software and Services Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Molecular Cytogenetics Market, By Technology, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Comparative Genomic Hybridization (CGH) Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia-Pacific Array-based CGH Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Standard CGH Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia-Pacific Florescence In Situ Hybridization (FISH) Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia-Pacific In Situ Hybridization (ISH) Market, By Region, From 2021 to 2026 (USD Million)
  15. Asia-Pacific Other Techniques Market, By Region, From 2021 to 2026 (USD Million)
  16. Asia-Pacific Molecular Cytogenetics Market, By Application, From 2021 to 2026 (USD Million)
  17. Asia-Pacific Genetic Disorders Market, By Region, From 2021 to 2026 (USD Million)
  18. Asia-Pacific Cancer Market, By Region, From 2021 to 2026 (USD Million)
  19. Asia-Pacific Personalized Medicine Market, By Region, From 2021 to 2026 (USD Million)
  20. Asia-Pacific Other Applications Market, By Region, From 2021 to 2026 (USD Million)
  21. Asia-Pacific Molecular Cytogenetics Market, By End User, From 2021 to 2026 (USD Million)
  22. Asia-Pacific Clinical and Research Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  23. Asia-Pacific Academic Research Institutes Market, By Region, From 2021 to 2026 (USD Million)
  24. Asia-Pacific Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Million)
  25. Asia-Pacific Others End Users Market, By Region, From 2021 to 2026 (USD Million)
  26. Japan Molecular Cytogenetics Market, By Product & Service, From 2021 to 2026 (USD Million)
  27. Japan Molecular Cytogenetics Market, By Technology, From 2021 to 2026 (USD Million)
  28. Japan Molecular Cytogenetics Market, By Application, From 2021 to 2026 (USD Million)
  29. Japan Molecular Cytogenetics Market, By End User, From 2021 to 2026 (USD Million)
  30. China Molecular Cytogenetics Market, By Product & Service, From 2021 to 2026 (USD Million)
  31. China Molecular Cytogenetics Market, By Technology, From 2021 to 2026 (USD Million)
  32. China Molecular Cytogenetics Market, By Application, From 2021 to 2026 (USD Million)
  33. China Molecular Cytogenetics Market, By End User, From 2021 to 2026 (USD Million)
  34. India Molecular Cytogenetics Market, By Product & Service, From 2021 to 2026 (USD Million)
  35. India Molecular Cytogenetics Market, By Technology, From 2021 to 2026 (USD Million)
  36. India Molecular Cytogenetics Market, By Application, From 2021 to 2026 (USD Million)
  37. India Molecular Cytogenetics Market, By End User, From 2021 to 2026 (USD Million)
  38. Australia Molecular Cytogenetics Market, By Product & Service, From 2021 to 2026 (USD Million)
  39. Australia Molecular Cytogenetics Market, By Technology, From 2021 to 2026 (USD Million)
  40. Australia Molecular Cytogenetics Market, By Application, From 2021 to 2026 (USD Million)
  41. Australia Molecular Cytogenetics Market, By End User, From 2021 to 2026 (USD Million)
  42. South Korea Molecular Cytogenetics Market, By Product & Service, From 2021 to 2026 (USD Million)
  43. South Korea Molecular Cytogenetics Market, By Technology, From 2021 to 2026 (USD Million)
  44. South Korea Molecular Cytogenetics Market, By Application, From 2021 to 2026 (USD Million)
  45. South Korea Molecular Cytogenetics Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample